1. AHRO : Austin Health Research Online

Jonathan S Cebon

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Jonathan S Cebon
Full Name
Cebon, Jonathan S
 
Department
 
ORCID
Loading... 3 0 20 0 false

Publications

Refined By:
Author:  Jackson, Heather M
Author:  Davis, Ian D
Date Issued:  [2000 TO 2009]

Results 1-8 of 8 (Search time: 0.005 seconds).

Publication YearTitleAuthor(s)
110-Mar-2009Regulatory T-cell-mediated attenuation of T-cell responses to the NY-ESO-1 ISCOMATRIX vaccine in patients with advanced malignant melanoma.Nicholaou, Theo; Ebert, Lisa M; Davis, Ian D; McArthur, Grant A; Jackson, Heather M; Dimopoulos, Nektaria; Tan, Bee; Maraskovsky, Eugene; Miloradovic, Lena; Hopkins, Wendie; Pan, Linda; Venhaus, Ralph; Hoffman, Eric W; Chen, Weisan; Cebon, Jonathan S 
227-Jan-2009A long, naturally presented immunodominant epitope from NY-ESO-1 tumor antigen: implications for cancer vaccine design.Ebert, Lisa M; Liu, Yu Chih; Clements, Craig S; Robson, Neil C; Jackson, Heather M; Markby, Jessica L; Dimopoulos, Nektaria; Tan, Bee Shin; Luescher, Immanuel F; Davis, Ian D; Rossjohn, Jamie; Cebon, Jonathan S ; Purcell, Anthony W; Chen, Weisan
310-Sep-2006Blood dendritic cells generated with Flt3 ligand and CD40 ligand prime CD8+ T cells efficiently in cancer patients.Davis, Ian D; Chen, Qiyuan; Morris, Leone; Quirk, Juliet; Stanley, Maureen; Tavarnesi, Maria L; Parente, Phillip; Cavicchiolo, Tina; Hopkins, Wendie; Jackson, Heather M; Dimopoulos, Nektaria; Tai, Tsin Yee; MacGregor, Duncan; Browning, Judy; Svobodova, Suzanne; Caron, Dania; Maraskovsky, Eugene; Old, Lloyd J; Chen, Weisan; Cebon, Jonathan S 
415-May-2006Striking immunodominance hierarchy of naturally occurring CD8+ and CD4+ T cell responses to tumor antigen NY-ESO-1.Jackson, Heather M; Dimopoulos, Nektaria; Mifsud, Nicole A; Tai, Tsin Yee; Chen, Qiyuan; Svobodova, Suzanne; Browning, Judy; Luescher, Immanuel F; Stockert, Lisa; Old, Lloyd J; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
523-Sep-2004The impact of imiquimod, a Toll-like receptor-7 ligand (TLR7L), on the immunogenicity of melanoma peptide vaccination with adjuvant Flt3 ligand.Shackleton, Mark; Davis, Ian D; Hopkins, Wendie; Jackson, Heather M; Dimopoulos, Nektaria; Tai, Tsin; Chen, Qiyuan; Parente, Phillip; Jefford, Michael; Masterman, Kelly-Anne; Caron, Dania; Chen, Weisan; Maraskovsky, Eugene; Cebon, Jonathan S 
61-Aug-2004A robust human T-cell culture method suitable for monitoring CD8+ and CD4+ T-cell responses from cancer clinical trial samples.Jackson, Heather M; Dimopoulos, Nektaria; Chen, Qiyuan; Luke, Tina; Yee Tai, Tsin; Maraskovsky, Eugene; Old, Lloyd J; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
714-Jun-2004Immunodominant CD4+ responses identified in a patient vaccinated with full-length NY-ESO-1 formulated with ISCOMATRIX adjuvant.Chen, Qiyuan; Jackson, Heather M; Parente, Phillip; Luke, Tina; Rizkalla, Mark; Tai, Tsin Yee; Zhu, He-Cheng; Mifsud, Nicole A; Dimopoulos, Nektaria; Masterman, Kelly-Anne; Hopkins, Wendie; Goldie, Heather; Maraskovsky, Eugene; Green, Simon; Miloradovic, Lena; McCluskey, James; Old, Lloyd J; Davis, Ian D; Cebon, Jonathan S ; Chen, Weisan
81-Feb-2000A direct comparison of cytolytic T-lymphocyte responses to Melan-A peptides in vitro: differential immunogenicity of Melan-A27-35 and Melan-A26-35.Chen, Q; Jackson, Heather M; Cebon, Jonathan S ; Gibbs, P; Davis, Ian D; Trapani, Joseph A